On January 7, Hikal Ltd. announced that it has completed a contract manufacturing agreement for supply of active pharmaceutical ingredients (API’s) with Pfizer Inc., a global leader in Pharmaceuticals.
“We are extremely pleased to be selected as a long term contract manufacturer by Pfizer,” said Jai Hiremath, vice chairman and managing director of Hikal Ltd. “This agreement will have a substantial impact on our Pharmaceutical business in the coming years”.
"We look forward to working with Hikal, a respected contract manufacturing company and are delighted that they are able to contribute towards supply of APIs for Pfizer products", said Mr. Peter Stevenson, vice-president, Global Contract Manufacturing, Procurement and Pfizer Center Source, Pfizer Inc.
Terms of the agreement were not disclosed.
